DNMT1 and non-small cell lung carcinoma: Positive DNMT1 staining was seen in 57.6% of patients carrying the wild type but 96.2% of the patients with the mutated KRAS. Positive staining for DNMT1 but negative staining for DNMT3a was most frequent in NSCLC patients when the KRAS mutational status was ignored.